TreeWAS – Variant ID: rs6868545

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E89.0 Postprocedural hypothyroidism	0.307	0.693	0.000
E86 Volume depletion	0.306	0.694	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.303	0.697	0.000
E70-E90 Metabolic disorders	0.300	0.700	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.256	0.744	0.000
E88 Other metabolic disorders	0.253	0.747	0.000
E74 Other disorders of carbohydrate metabolism	0.236	0.764	0.000
E20-E35 Disorders of other endocrine glands	0.235	0.765	0.000
E89.2 Postprocedural hypoparathyroidism	0.229	0.771	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.219	0.781	0.000
E89.3 Postprocedural hypopituitarism	0.218	0.781	0.000
E10-E14 Diabetes mellitus	0.218	0.782	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.217	0.782	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.217	0.782	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.217	0.782	0.000
E89.5 Postprocedural testicular hypofunction	0.217	0.782	0.000
E89.4 Postprocedural ovarian failure	0.217	0.782	0.000
E89.1 Postprocedural hypoinsulinaemia	0.217	0.782	0.000
E84 Cystic fibrosis	0.215	0.785	0.000
E79 Disorders of purine and pyrimidine metabolism	0.215	0.785	0.000
E77 Disorders of glycoprotein metabolism	0.215	0.785	0.000
E76 Disorders of glycosaminoglycan metabolism	0.215	0.785	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.215	0.785	0.000
E73 Lactose intolerance	0.215	0.785	0.000
E72 Other disorders of amino-acid metabolism	0.215	0.785	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.215	0.785	0.000
E70 Disorders of aromatic amino-acid metabolism	0.215	0.785	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.215	0.785	0.000
E10.9 Without complications	0.213	0.787	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.213	0.787	0.000
E10 Insulin-dependent diabetes mellitus	0.208	0.792	0.000
E85 Amyloidosis	0.204	0.796	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.202	0.798	0.000
E65-E68 Obesity and other hyperalimentation	0.200	0.800	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.199	0.801	0.000
E22 Hyperfunction of pituitary gland	0.198	0.802	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.190	0.810	0.000
E29 Testicular dysfunction	0.189	0.810	0.000
E00-E07 Disorders of thyroid gland	0.189	0.811	0.000
E50-E64 Other nutritional deficiencies	0.183	0.816	0.000
E21.3 Hyperparathyroidism, unspecified	0.182	0.818	0.000
E88.9 Metabolic disorder, unspecified	0.181	0.819	0.000
E88.8 Other specified metabolic disorders	0.181	0.819	0.000
E88.3 Tumour lysis syndrome	0.181	0.819	0.000
E88.2 Lipomatosis, not elsewhere classified	0.181	0.819	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.181	0.819	0.000
E83 Disorders of mineral metabolism	0.180	0.820	0.000
E27 Other disorders of adrenal gland	0.176	0.824	0.000
E34 Other endocrine disorders	0.176	0.824	0.000
E28 Ovarian dysfunction	0.174	0.826	0.000
E65 Localised adiposity	0.174	0.826	0.000
E13 Other specified diabetes mellitus	0.172	0.828	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.169	0.831	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.169	0.831	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.169	0.831	0.000
E74.2 Disorders of galactose metabolism	0.169	0.831	0.000
E74.1 Disorders of fructose metabolism	0.169	0.831	0.000
E74.0 Glycogen storage disease	0.169	0.831	0.000
E20 Hypoparathyroidism	0.169	0.831	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.169	0.831	0.000
E32 Diseases of thymus	0.169	0.831	0.000
E31 Polyglandular dysfunction	0.169	0.831	0.000
E30 Disorders of puberty, not elsewhere classified	0.169	0.831	0.000
E25 Adrenogenital disorders	0.169	0.831	0.000
E06 Thyroiditis	0.169	0.831	0.000
E16 Other disorders of pancreatic internal secretion	0.163	0.837	0.000
E24 Cushing's syndrome	0.162	0.838	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.160	0.840	0.000
E10.8 With unspecified complications	0.159	0.841	0.000
E22.0 Acromegaly and pituitary gigantism	0.158	0.842	0.000
E23 Hypofunction and other disorders of pituitary gland	0.157	0.843	0.000
E29.1 Testicular hypofunction	0.157	0.843	0.000
E26 Hyperaldosteronism	0.157	0.843	0.000
E12 Malnutrition-related diabetes mellitus	0.156	0.844	0.000
E10.0 With coma	0.156	0.844	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.154	0.845	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.154	0.845	0.000
E70.3 Albinism	0.154	0.845	0.000
E70.2 Disorders of tyrosine metabolism	0.154	0.845	0.000
E70.1 Other hyperphenylalaninaemias	0.154	0.845	0.000
E70.0 Classical phenylketonuria	0.154	0.845	0.000
E71.3 Disorders of fatty-acid metabolism	0.154	0.845	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.154	0.845	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.154	0.845	0.000
E71.0 Maple-syrup-urine disease	0.154	0.845	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.154	0.845	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.154	0.845	0.000
E72.5 Disorders of glycine metabolism	0.154	0.845	0.000
E72.4 Disorders of ornithine metabolism	0.154	0.845	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.154	0.845	0.000
E72.2 Disorders of urea cycle metabolism	0.154	0.845	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.154	0.845	0.000
E72.0 Disorders of amino-acid transport	0.154	0.845	0.000
E73.9 Lactose intolerance, unspecified	0.154	0.845	0.000
E73.8 Other lactose intolerance	0.154	0.845	0.000
E73.1 Secondary lactase deficiency	0.154	0.845	0.000
E73.0 Congenital lactase deficiency	0.154	0.845	0.000
E75.6 Lipid storage disorder, unspecified	0.154	0.845	0.000
E75.5 Other lipid storage disorders	0.154	0.845	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.154	0.845	0.000
E75.3 Sphingolipidosis, unspecified	0.154	0.845	0.000
E75.2 Other sphingolipidosis	0.154	0.845	0.000
E75.1 Other gangliosidosis	0.154	0.845	0.000
E75.0 GM2 gangliosidosis	0.154	0.845	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.154	0.845	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.154	0.845	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.154	0.845	0.000
E76.2 Other mucopolysaccharidoses	0.154	0.845	0.000
E76.1 Mucopolysaccharidosis, type II	0.154	0.845	0.000
E76.0 Mucopolysaccharidosis, type I	0.154	0.845	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.154	0.845	0.000
E77.8 Other disorders of glycoprotein metabolism	0.154	0.845	0.000
E77.1 Defects in glycoprotein degradation	0.154	0.845	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.154	0.845	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.154	0.845	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.154	0.845	0.000
E79.1 Lesch-Nyhan syndrome	0.154	0.845	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.154	0.845	0.000
E84.9 Cystic fibrosis, unspecified	0.154	0.845	0.000
E84.8 Cystic fibrosis with other manifestations	0.154	0.845	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.154	0.845	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.154	0.845	0.000
E06.3 Autoimmune thyroiditis	0.154	0.846	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.153	0.847	0.000
E80.6 Other disorders of bilirubin metabolism	0.153	0.847	0.000
E80.5 Crigler-Najjar syndrome	0.153	0.847	0.000
E80.3 Defects of catalase and peroxydase	0.153	0.847	0.000
E80.2 Other porphyria	0.153	0.847	0.000
E80.1 Porphyria cutanea tarda	0.153	0.847	0.000
E80.0 Hereditary erythropoietic porphyria	0.153	0.847	0.000
E80.4 Gilbert's syndrome	0.150	0.850	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.150	0.850	0.000
E10.7 With multiple complications	0.149	0.851	0.000
E10.6 With other specified complications	0.149	0.851	0.000
E40-E46 Malnutrition	0.149	0.851	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.147	0.853	0.000
E85.9 Amyloidosis, unspecified	0.146	0.854	0.000
E85.8 Other amyloidosis	0.146	0.854	0.000
E85.3 Secondary systemic amyloidosis	0.146	0.854	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.146	0.854	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.146	0.854	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.146	0.854	0.000
E22.1 Hyperprolactinaemia	0.145	0.855	0.000
E15 Nondiabetic hypoglycaemic coma	0.145	0.855	0.000
E67 Other hyperalimentation	0.143	0.856	0.000
E68 Sequelae of hyperalimentation	0.143	0.856	0.000
E10.1 With ketoacidosis	0.143	0.857	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.143	0.857	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.143	0.857	0.000
E21.4 Other specified disorders of parathyroid gland	0.143	0.857	0.000
E21.2 Other hyperparathyroidism	0.143	0.857	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.142	0.858	0.000
E22.8 Other hyperfunction of pituitary gland	0.142	0.858	0.000
E55 Vitamin D deficiency	0.142	0.858	0.000
E28.3 Primary ovarian failure	0.139	0.861	0.000
E13.9 Without complications	0.139	0.861	0.000
E29.9 Testicular dysfunction, unspecified	0.136	0.864	0.000
E29.8 Other testicular dysfunction	0.136	0.864	0.000
E29.0 Testicular hyperfunction	0.136	0.864	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.135	0.864	0.000
E00 Congenital iodine-deficiency syndrome	0.135	0.864	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.135	0.864	0.000
E16.2 Hypoglycaemia, unspecified	0.135	0.865	0.000
E85.4 Organ-limited amyloidosis	0.135	0.865	0.000
E34.0 Carcinoid syndrome	0.133	0.866	0.000
E07 Other disorders of thyroid	0.133	0.867	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.132	0.868	0.000
E63 Other nutritional deficiencies	0.132	0.868	0.000
E56 Other vitamin deficiencies	0.132	0.868	0.000
E51 Thiamine deficiency	0.132	0.868	0.000
E50 Vitamin A deficiency	0.132	0.868	0.000
E60 Dietary zinc deficiency	0.132	0.868	0.000
E59 Dietary selenium deficiency	0.132	0.868	0.000
E58 Dietary calcium deficiency	0.132	0.868	0.000
E54 Ascorbic acid deficiency	0.132	0.868	0.000
E52 Niacin deficiency [pellagra]	0.132	0.868	0.000
E53 Deficiency of other B group vitamins	0.131	0.869	0.000
E10.2 With renal complications	0.131	0.869	0.000
E83.3 Disorders of phosphorus metabolism	0.131	0.869	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.131	0.869	0.000
E10.5 With peripheral circulatory complications	0.130	0.870	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.129	0.871	0.000
E83.8 Other disorders of mineral metabolism	0.129	0.871	0.000
E83.2 Disorders of zinc metabolism	0.129	0.871	0.000
E83.0 Disorders of copper metabolism	0.129	0.871	0.000
E83.5 Disorders of calcium metabolism	0.128	0.872	0.000
E83.4 Disorders of magnesium metabolism	0.128	0.872	0.000
E27.5 Adrenomedullary hyperfunction	0.126	0.874	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.126	0.874	0.000
E27.2 Addisonian crisis	0.126	0.874	0.000
E27.0 Other adrenocortical overactivity	0.126	0.874	0.000
E34.9 Endocrine disorder, unspecified	0.126	0.874	0.000
E34.8 Other specified endocrine disorders	0.126	0.874	0.000
E34.5 Androgen resistance syndrome	0.126	0.874	0.000
E34.4 Constitutional tall stature	0.126	0.874	0.000
E34.3 Short stature, not elsewhere classified	0.126	0.874	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.126	0.874	0.000
E34.1 Other hypersecretion of intestinal hormones	0.126	0.874	0.000
E28.9 Ovarian dysfunction, unspecified	0.125	0.875	0.000
E28.8 Other ovarian dysfunction	0.125	0.875	0.000
E28.1 Androgen excess	0.125	0.875	0.000
E28.0 Oestrogen excess	0.125	0.875	0.000
E27.9 Disorder of adrenal gland, unspecified	0.123	0.877	0.000
E13.8 With unspecified complications	0.123	0.877	0.000
E13.7 With multiple complications	0.123	0.877	0.000
E13.6 With other specified complications	0.123	0.877	0.000
E13.5 With peripheral circulatory complications	0.123	0.877	0.000
E13.4 With neurological complications	0.123	0.877	0.000
E13.3 With ophthalmic complications	0.123	0.877	0.000
E13.2 With renal complications	0.123	0.877	0.000
E13.1 With ketoacidosis	0.123	0.877	0.000
E13.0 With coma	0.123	0.877	0.000
E20.9 Hypoparathyroidism, unspecified	0.122	0.878	0.000
E20.8 Other hypoparathyroidism	0.121	0.878	0.000
E20.1 Pseudohypoparathyroidism	0.121	0.878	0.000
E20.0 Idiopathic hypoparathyroidism	0.121	0.878	0.000
E27.8 Other specified disorders of adrenal gland	0.121	0.879	0.000
E27.1 Primary adrenocortical insufficiency	0.121	0.879	0.000
E25.9 Adrenogenital disorder, unspecified	0.121	0.879	0.000
E25.8 Other adrenogenital disorders	0.121	0.879	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.121	0.879	0.000
E30.9 Disorder of puberty, unspecified	0.121	0.879	0.000
E30.8 Other disorders of puberty	0.121	0.879	0.000
E30.1 Precocious puberty	0.121	0.879	0.000
E30.0 Delayed puberty	0.121	0.879	0.000
E31.9 Polyglandular dysfunction, unspecified	0.121	0.879	0.000
E31.8 Other polyglandular dysfunction	0.121	0.879	0.000
E31.1 Polyglandular hyperfunction	0.121	0.879	0.000
E31.0 Autoimmune polyglandular failure	0.121	0.879	0.000
E32.9 Disease of thymus, unspecified	0.121	0.879	0.000
E32.8 Other diseases of thymus	0.121	0.879	0.000
E32.1 Abscess of thymus	0.121	0.879	0.000
E32.0 Persistent hyperplasia of thymus	0.121	0.879	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.121	0.879	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.121	0.879	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.121	0.879	0.000
E06.9 Thyroiditis, unspecified	0.121	0.879	0.000
E06.5 Other chronic thyroiditis	0.121	0.879	0.000
E06.4 Drug-induced thyroiditis	0.121	0.879	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.121	0.879	0.000
E06.1 Subacute thyroiditis	0.121	0.879	0.000
E06.0 Acute thyroiditis	0.121	0.879	0.000
E61 Deficiency of other nutrient elements	0.119	0.881	0.000
E10.4 With neurological complications	0.117	0.882	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.117	0.883	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.117	0.883	0.000
E16.4 Abnormal secretion of gastrin	0.117	0.883	0.000
E16.3 Increased secretion of glucagon	0.117	0.883	0.000
E16.1 Other hypoglycaemia	0.117	0.883	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.117	0.883	0.000
E24.8 Other Cushing's syndrome	0.116	0.884	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.116	0.884	0.000
E24.3 Ectopic ACTH syndrome	0.116	0.884	0.000
E24.2 Drug-induced Cushing's syndrome	0.116	0.884	0.000
E24.1 Nelson's syndrome	0.116	0.884	0.000
E24.0 Pituitary-dependent Cushing's disease	0.116	0.884	0.000
E05.9 Thyrotoxicosis, unspecified	0.116	0.884	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.116	0.884	0.000
E23.2 Diabetes insipidus	0.114	0.886	0.000
E66 Obesity	0.114	0.886	0.000
E23.7 Disorder of pituitary gland, unspecified	0.113	0.887	0.000
E23.6 Other disorders of pituitary gland	0.113	0.887	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.113	0.887	0.000
E23.1 Drug-induced hypopituitarism	0.113	0.887	0.000
E26.9 Hyperaldosteronism, unspecified	0.113	0.887	0.000
E26.8 Other hyperaldosteronism	0.113	0.887	0.000
E26.1 Secondary hyperaldosteronism	0.113	0.887	0.000
E55.9 Vitamin D deficiency, unspecified	0.112	0.887	0.000
E28.2 Polycystic ovarian syndrome	0.112	0.888	0.000
E12.9 Without complications	0.112	0.888	0.000
E12.8 With unspecified complications	0.112	0.888	0.000
E12.7 With multiple complications	0.112	0.888	0.000
E12.6 With other specified complications	0.112	0.888	0.000
E12.5 With peripheral circulatory complications	0.112	0.888	0.000
E12.4 With neurological complications	0.112	0.888	0.000
E12.3 With ophthalmic complications	0.112	0.888	0.000
E12.2 With renal complications	0.112	0.888	0.000
E12.1 With ketoacidosis	0.112	0.888	0.000
E12.0 With coma	0.112	0.888	0.000
E78.2 Mixed hyperlipidaemia	0.111	0.889	0.000
E24.9 Cushing's syndrome, unspecified	0.109	0.891	0.000
E05.8 Other thyrotoxicosis	0.108	0.892	0.000
E05.5 Thyroid crisis or storm	0.108	0.892	0.000
E05.4 Thyrotoxicosis factitia	0.108	0.892	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.108	0.892	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.108	0.892	0.000
E21.0 Primary hyperparathyroidism	0.107	0.892	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.107	0.893	0.000
E45 Retarded development following protein-energy malnutrition	0.107	0.893	0.000
E43 Unspecified severe protein-energy malnutrition	0.107	0.893	0.000
E42 Marasmic kwashiorkor	0.107	0.893	0.000
E41 Nutritional marasmus	0.107	0.893	0.000
E40 Kwashiorkor	0.107	0.893	0.000
E14 Unspecified diabetes mellitus	0.107	0.893	0.000
E04 Other non-toxic goitre	0.106	0.894	0.000
E67.8 Other specified hyperalimentation	0.103	0.897	0.000
E67.3 Hypervitaminosis D	0.103	0.897	0.000
E67.2 Megavitamin-B6 syndrome	0.103	0.897	0.000
E67.1 Hypercarotenaemia	0.103	0.897	0.000
E67.0 Hypervitaminosis A	0.103	0.897	0.000
E55.0 Rickets, active	0.102	0.898	0.000
E26.0 Primary hyperaldosteronism	0.101	0.899	0.000
E23.0 Hypopituitarism	0.099	0.900	0.000
E11 Non-insulin-dependent diabetes mellitus	0.099	0.901	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.097	0.903	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.097	0.903	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.097	0.903	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.097	0.903	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.097	0.903	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.097	0.903	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.097	0.903	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.097	0.903	0.000
E07.8 Other specified disorders of thyroid	0.096	0.904	0.000
E07.1 Dyshormogenetic goitre	0.096	0.904	0.000
E07.0 Hypersecretion of calcitonin	0.096	0.904	0.000
E50.9 Vitamin A deficiency, unspecified	0.095	0.905	0.000
E50.8 Other manifestations of vitamin A deficiency	0.095	0.905	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.095	0.905	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.095	0.905	0.000
E50.5 Vitamin A deficiency with night blindness	0.095	0.905	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.095	0.905	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.095	0.905	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.095	0.905	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.095	0.905	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.095	0.905	0.000
E51.9 Thiamine deficiency, unspecified	0.095	0.905	0.000
E51.8 Other manifestations of thiamine deficiency	0.095	0.905	0.000
E51.2 Wernicke's encephalopathy	0.095	0.905	0.000
E51.1 Beriberi	0.095	0.905	0.000
E56.9 Vitamin deficiency, unspecified	0.095	0.905	0.000
E56.8 Deficiency of other vitamins	0.095	0.905	0.000
E56.1 Deficiency of vitamin K	0.095	0.905	0.000
E56.0 Deficiency of vitamin E	0.095	0.905	0.000
E63.9 Nutritional deficiency, unspecified	0.095	0.905	0.000
E63.8 Other specified nutritional deficiencies	0.095	0.905	0.000
E63.1 Imbalance of constituents of food intake	0.095	0.905	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.095	0.905	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.095	0.905	0.000
E64.8 Sequelae of other nutritional deficiencies	0.095	0.905	0.000
E64.3 Sequelae of rickets	0.095	0.905	0.000
E64.2 Sequelae of vitamin C deficiency	0.095	0.905	0.000
E64.1 Sequelae of vitamin A deficiency	0.095	0.905	0.000
E64.0 Sequelae of protein-energy malnutrition	0.095	0.905	0.000
E53.9 Vitamin B deficiency, unspecified	0.094	0.906	0.000
E53.1 Pyridoxine deficiency	0.094	0.906	0.000
E53.0 Riboflavin deficiency	0.094	0.906	0.000
E53.8 Deficiency of other specified B group vitamins	0.094	0.906	0.000
E07.9 Disorder of thyroid, unspecified	0.093	0.907	0.000
E83.1 Disorders of iron metabolism	0.092	0.908	0.000
E04.1 Non-toxic single thyroid nodule	0.090	0.910	0.000
E61.9 Deficiency of nutrient element, unspecified	0.086	0.914	0.000
E61.8 Deficiency of other specified nutrient elements	0.086	0.914	0.000
E61.7 Deficiency of multiple nutrient elements	0.086	0.914	0.000
E61.6 Vanadium deficiency	0.086	0.914	0.000
E61.5 Molybdenum deficiency	0.086	0.914	0.000
E61.4 Chromium deficiency	0.086	0.914	0.000
E61.3 Manganese deficiency	0.086	0.914	0.000
E61.2 Magnesium deficiency	0.086	0.914	0.000
E61.0 Copper deficiency	0.086	0.914	0.000
E66.0 Obesity due to excess calories	0.085	0.915	0.000
E78.4 Other hyperlipidaemia	0.084	0.916	0.000
E66.8 Other obesity	0.083	0.917	0.000
E78.6 Lipoprotein deficiency	0.083	0.917	0.000
E78.3 Hyperchylomicronaemia	0.083	0.917	0.000
E78.1 Pure hyperglyceridaemia	0.083	0.917	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.083	0.917	0.000
E03 Other hypothyroidism	0.082	0.918	0.000
E66.1 Drug-induced obesity	0.082	0.918	0.000
E11.8 With unspecified complications	0.081	0.919	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.078	0.921	0.000
E11.9 Without complications	0.078	0.922	0.000
E44.1 Mild protein-energy malnutrition	0.077	0.923	0.000
E44.0 Moderate protein-energy malnutrition	0.077	0.923	0.000
E14.8 With unspecified complications	0.077	0.923	0.000
E14.7 With multiple complications	0.077	0.923	0.000
E14.6 With other specified complications	0.077	0.923	0.000
E14.5 With peripheral circulatory complications	0.077	0.923	0.000
E14.4 With neurological complications	0.077	0.923	0.000
E14.2 Withrenal complications	0.077	0.923	0.000
E14.1 With ketoacidosis	0.077	0.923	0.000
E14.0 With coma	0.077	0.923	0.000
E11.3 With ophthalmic complications	0.076	0.924	0.000
E04.8 Other specified non-toxic goitre	0.076	0.924	0.000
E04.0 Non-toxic diffuse goitre	0.076	0.924	0.000
E14.3 With ophthalmic complications	0.074	0.926	0.000
E61.1 Iron deficiency	0.073	0.927	0.000
E46 Unspecified protein-energy malnutrition	0.072	0.927	0.001
E11.7 With multiple complications	0.071	0.929	0.000
E11.0 With coma	0.070	0.929	0.000
E78.9 Disorder of lipoprotein metabolism, unspecified	0.068	0.932	0.000
E11.2 With renal complications	0.065	0.935	0.000
E78.8 Other disorders of lipoprotein metabolism	0.065	0.935	0.000
E11.6 With other specified complications	0.063	0.936	0.000
E10.3 With ophthalmic complications	0.063	0.937	0.001
E11.4 With neurological complications	0.062	0.938	0.000
E03.8 Other specified hypothyroidism	0.060	0.940	0.000
E03.5 Myxoedema coma	0.059	0.941	0.000
E03.4 Atrophy of thyroid (acquired)	0.059	0.941	0.000
E03.3 Postinfectious hypothyroidism	0.059	0.941	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.059	0.941	0.000
E03.1 Congenital hypothyroidism without goitre	0.059	0.941	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.059	0.941	0.000
E04.9 Non-toxic goitre, unspecified	0.052	0.948	0.000
E11.1 With ketoacidosis	0.048	0.952	0.000
E11.5 With peripheral circulatory complications	0.044	0.955	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.044	0.956	0.000
E66.9 Obesity, unspecified	0.043	0.957	0.000
E04.2 Non-toxic multinodular goitre	0.043	0.957	0.000
E87.6 Hypokalaemia	0.040	0.960	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.037	0.963	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.036	0.964	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.035	0.965	0.000
Y40 Systemic antibiotics	0.035	0.965	0.000
Y40.8 Other systemic antibiotics	0.034	0.966	0.000
E14.9 Without complications	0.034	0.966	0.000
Chapter XX External causes of morbidity and mortality	0.033	0.967	0.000
E87.4 Mixed disorder of acid-base balance	0.032	0.968	0.000
E87.2 Acidosis	0.032	0.968	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.031	0.969	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.030	0.970	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.030	0.970	0.000
E87.3 Alkalosis	0.030	0.970	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.030	0.970	0.000
Y52 Agents primarily affecting the cardiovascular system	0.029	0.971	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.029	0.971	0.000
W00-W19 Falls	0.029	0.971	0.000
Y48 Anaesthetics and therapeutic gases	0.028	0.971	0.000
W20-W49 Exposure to inanimate mechanical forces	0.028	0.972	0.000
Y40.3 Macrolides	0.028	0.972	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.028	0.972	0.000
Y41.0 Sulphonamides	0.027	0.973	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.027	0.973	0.000
Y57 Other and unspecified drugs and medicaments	0.027	0.973	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.027	0.973	0.000
W50-W64 Exposure to animate mechanical forces	0.027	0.973	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.027	0.973	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.027	0.973	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.027	0.973	0.000
Y59 Other and unspecified vaccines and biological substances	0.027	0.973	0.000
Y58 Bacterial vaccines	0.027	0.973	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.027	0.973	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.027	0.973	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.027	0.973	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.027	0.973	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.026	0.974	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.026	0.974	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.026	0.974	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.026	0.974	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.026	0.974	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.026	0.974	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.026	0.974	0.000
Y51.0 Anticholinesterase agents	0.026	0.974	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.026	0.974	0.000
V95-V97 Air and space transport accidents	0.026	0.974	0.000
Y40.7 Antifungal antibiotics, systemically used	0.025	0.975	0.000
Y40.6 Rifamycins	0.025	0.975	0.000
Y40.5 Aminoglycosides	0.025	0.975	0.000
Y40.4 Tetracyclines	0.025	0.975	0.000
Y40.2 Chloramphenicol group	0.025	0.975	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.025	0.975	0.000
X20-X29 Contact with venomous animals and plants	0.025	0.975	0.000
V01-V09 Pedestrian injured in transport accident	0.025	0.975	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.025	0.975	0.000
W20 Struck by thrown, projected or falling object	0.025	0.975	0.000
X50-X57 Overexertion, travel and privation	0.025	0.975	0.000
V40-V49 Car occupant injured in transport accident	0.025	0.975	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.024	0.975	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.024	0.976	0.000
Y44 Agents primarily affecting blood constituents	0.024	0.976	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.024	0.976	0.000
Y35-Y36 Legal intervention and operations of war	0.024	0.976	0.000
Y10-Y34 Event of undetermined intent	0.024	0.976	0.000
Y00-Y09 Assault	0.024	0.976	0.000
X85-X99 Assault	0.024	0.976	0.000
X30-X39 Exposure to forces of nature	0.024	0.976	0.000
X10-X19 Contact with heat and hot substances	0.024	0.976	0.000
X00-X09 Exposure to smoke, fire and flames	0.024	0.976	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.024	0.976	0.000
W75-W84 Other accidental threats to breathing	0.024	0.976	0.000
W65-W74 Accidental drowning and submersion	0.024	0.976	0.000
V98-V99 Other and unspecified transport accidents	0.024	0.976	0.000
V90-V94 Water transport accidents	0.024	0.976	0.000
V70-V79 Bus occupant injured in transport accident	0.024	0.976	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.024	0.976	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.024	0.976	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.024	0.976	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.024	0.976	0.000
Y43 Primarily systemic agents	0.024	0.976	0.000
W55 Bitten or struck by other mammals	0.023	0.977	0.000
V10-V19 Pedal cyclist injured in transport accident	0.023	0.977	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.023	0.977	0.000
W19 Unspecified fall	0.023	0.977	0.000
V80-V89 Other land transport accidents	0.023	0.977	0.000
V20-V29 Motorcycle rider injured in transport accident	0.023	0.977	0.000
W10 Fall on and from stairs and steps	0.023	0.977	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.023	0.977	0.000
W17 Other fall from one level to another	0.023	0.977	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.023	0.977	0.000
W20.8 Other specified place	0.023	0.977	0.000
Y40.0 Penicillins	0.023	0.977	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations